Rhythm

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center enrolling patients to test stroke-reducing device

AUSTIN, Texas, Feb. 25, 2019 /PRNewswire/ — The Texas Cardiac Arrhythmia Institute at St. David’s Medical Center recently began enrolling patients to participate in the DIAMOND-AF II clinical trial to examine the effectiveness of the DiamondTemp System in treating patients with persistent atrial fibrillation, or A Fib. A Fib is a type of […]

BioSig Announces Successful First-In-Human Use of PURE EP System

Santa Monica, CA, Feb. 20, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the Company successfully conducted first patient cases using PURE EP(tm) System, its […]

AtriCure Announces The Society of Thoracic Surgeons Has Endorsed the Company’s Advanced Ablation Courses in the United States

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatment for atrial fibrillation (Afib) and left atrial appendage management, today announced that The Society of Thoracic Surgeons (STS) has endorsed its Advanced Ablation course for both physicians and fellows. The course provides surgeons and other medical professionals with […]

Texas Cardiac Arrhythmia Institute of St. David’s Medical Center is the first in the United States to treat patient under study for evaluation of the ablation catheter-balloon for the treatment of atrial fibrillation

AUSTIN, Texas , February 13, 2019 / PRNewswire / – The Texas Cardiac Arrhythmia Institute (TCAI) of St. David’s Medical Center recently conducted the first procedure in the United States using the new multi-electrode radiofrequency (RF) ablation balloon catheter, HELIOSTAR as part of the STELLAR study. The aim of the study is […]

VitalConnect Unveils Vista Solution 2.0 to Improve Real-time Patient Monitoring for Earlier Intervention

SAN JOSE, Calif., Feb. 12, 2019 /PRNewswire/ — VitalConnect, Inc., a leader in wearable biosensor technology for wireless monitoring, is introducing today at HIMSS19 Vista Solution 2.01, ushering in the next generation of healthcare where specific health outcomes can be detected through National Early Warning Scores (NEWS). Vista Solution 2.0 will include the […]

FierceMedTech Names FineHeart as One of Its “Fierce 15” Med Tech Companies of 2018

BORDEAUX, France–(BUSINESS WIRE)–FineHeart today announced that it has been named by FierceMedTech as one of 2018’s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry. FineHeart’s technology, the ICOMS (Implantable Cardiac Output Management System), is dedicated to the treatment of severe heart […]

Kardium Announces New Financing to Commercialize the Globe System for the Treatment of Atrial Fibrillation

VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, announced today that it has raised an undisclosed amount in a new financing round. The financing was led by funds and accounts advised by T. Rowe Price Associates, Inc., and included participation from […]

New Patent Issuances Strengthen InCarda Therapeutics’ Intellectual Property Portfolio Covering Novel Inhaled Cardiovascular Therapies

SAN FRANCISCO, Feb. 07, 2019 (GLOBE NEWSWIRE) — InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today announced that new U.S. patents have been issued by the U.S. Patent and Trademark Office (USPTO). The two new patents provide the company with significantly expanded […]

Correvio Announces Presentation Of Brinavess Data At Belgian Society Of Cardiology 2019 Annual Congress

VANCOUVER, Feb. 7, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced the presentation of clinical data highlighting the low  rate of hospitalization in patients treated with Brinavess® (vernakalant hydrochloride, IV), its antiarrhythmic drug for the rapid conversion of recent onset atrial […]

Omron Healthcare and physIQ Partner to Transform Cardiovascular Patient Care

CHICAGO–(BUSINESS WIRE)–Omron Healthcare, Inc. and physIQ Inc. today announced a collaboration to integrate Omron’s innovative FDA-cleared device, HeartGuide®, the first wearable blood pressure monitor into the pinpointIQ®platform to monitor at-risk patients in an outpatient setting. The strategic collaboration aims to generate actionable clinical information for at-risk patients in an outpatient environment by leveraging […]